Bill Commons

NY S 2383

in committee

Relates to the classification of the drug xylazine as a controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine

New York · 2025-2026 Regular Session · upper

Description

Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

Introduced
—
Status date
—
Latest action
2026-01-07 — REFERRED TO HEALTH
Bill type
bill
Last updated
—

Sponsors

  • Mario Matteraprimary

Committees

Not provided by source.

Action timeline

  1. 2025-01-16

    REFERRED TO HEALTH

    referral-committee

  2. 2026-01-07

    REFERRED TO HEALTH

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

https://legislation.nysenate.gov/api/3/bills/2025-2026/S2383?summary=&detail=

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 2383. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.